Barclays PLC Prokidney Corp Ord Shs Cl A(Cy Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Barclays PLC holds 171,797 shares of PROK stock, worth $257,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,797
Previous 146,321
17.41%
Holding current value
$257,695
Previous $281,000
3.2%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PROK
# of Institutions
74Shares Held
47.5MCall Options Held
100KPut Options Held
16.4K-
Morgan Stanley New York, NY14MShares$21 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$18.5 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.28MShares$7.91 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$5.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.23MShares$3.35 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $92.3M